Your browser doesn't support javascript.
loading
Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU).
Jefferies, Kimberley; Drysdale, Simon B; Robinson, Hannah; Clutterbuck, Elizabeth Ann; Blackwell, Luke; McGinley, Joseph; Lin, Gu-Lung; Galal, Ushma; Nair, Harish; Aerssens, Jeroen; Öner, Deniz; Langedijk, Annefleur; Bont, Louis; Wildenbeest, Joanne G; Martinon-Torres, Federico; Rodríguez-Tenreiro Sánchez, Carmen; Nadel, Simon; Openshaw, Peter; Thwaites, Ryan; Widjojoatmodjo, Myra; Zhang, Linong; Nguyen, Thi Lien-Anh; Giaquinto, Carlo; Giordano, Giuseppe; Baraldi, Eugenio; Pollard, Andrew J.
Afiliación
  • Jefferies K; Department of Paediatrics, Oxford Vaccine Group, Oxford, United Kingdom.
  • Drysdale SB; Department of Paediatrics, Oxford Vaccine Group, Oxford, United Kingdom.
  • Robinson H; Department of Paediatrics, St George's University Hospital NHS Foundation Trust, London, United Kingdom.
  • Clutterbuck EA; Department of Paediatrics, Oxford Vaccine Group, Oxford, United Kingdom.
  • Blackwell L; Department of Paediatrics, Oxford Vaccine Group, Oxford, United Kingdom.
  • McGinley J; Department of Paediatrics, Oxford Vaccine Group, Oxford, United Kingdom.
  • Lin GL; Department of Paediatrics, Oxford Vaccine Group, Oxford, United Kingdom.
  • Galal U; Department of Paediatrics, Oxford Vaccine Group, Oxford, United Kingdom.
  • Nair H; Nuffield Department of Primary Care Health Sciences, Oxford, United Kingdom.
  • Aerssens J; Usher Institute, University of Edinburgh, Old Medical School, Edinburgh, United Kingdom.
  • Öner D; Infectious Diseases, Janssen Pharmaceutica NV, Beerse, Belgium.
  • Langedijk A; Infectious Diseases, Janssen Pharmaceutica NV, Beerse, Belgium.
  • Bont L; Department of Paediatrics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Wildenbeest JG; Department of Paediatrics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Martinon-Torres F; Department of Paediatrics, Immunology and Infectious Disease, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Rodríguez-Tenreiro Sánchez C; Translational Paediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
  • Nadel S; Genetics, Vaccines, Infections and Pediatrics Research Group, Instituto de Investigación Sanitaria de Santiago, University of Santiago de Compostela, Santiago de Compostela, Spain.
  • Openshaw P; Translational Paediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
  • Thwaites R; Genetics, Vaccines, Infections and Pediatrics Research Group, Instituto de Investigación Sanitaria de Santiago, University of Santiago de Compostela, Santiago de Compostela, Spain.
  • Widjojoatmodjo M; Department of Paediatrics, Imperial College, London, United Kingdom.
  • Zhang L; Faculty of Medicine, National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Nguyen TL; Faculty of Medicine, National Heart and Lung Institute, Imperial College, London, United Kingdom.
  • Giaquinto C; Janssen Vaccines and Prevention B.V., Leiden, The Netherlands.
  • Giordano G; Sanofi Pasteur, Cambridge, Massachusetts, USA.
  • Baraldi E; GSK Biologicals, Rixensart, Belgium.
  • Pollard AJ; Fondazione Penta Onlus, Torre di Ricerca Pediatrica, Padova, Italy.
J Infect Dis ; 222(Suppl 7): S658-S665, 2020 10 07.
Article en En | MEDLINE | ID: mdl-32794560
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Índice de Severidad de la Enfermedad / Infecciones por Virus Sincitial Respiratorio / Progresión de la Enfermedad Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Infant / Male País/Región como asunto: Europa Idioma: En Revista: J Infect Dis Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Índice de Severidad de la Enfermedad / Infecciones por Virus Sincitial Respiratorio / Progresión de la Enfermedad Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Infant / Male País/Región como asunto: Europa Idioma: En Revista: J Infect Dis Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido